Yakira Capital Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Yakira Capital Management’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-110,892	Closed	-$2.06M	–	390
2023 Q3	$2.06M	Buy	+110,892	New	+$1.25M	0.56%	60

Yakira Capital Management's ICPT Position: Q4 2023 in Review

Yakira Capital Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 110,892 shares — an estimated $2.06M sold.

Yakira Capital Management first reported a position in ICPT in Q3 2023 and held it in 1 quarter. The position peaked at $2.06M in Q3 2023. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

Yakira Capital Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
Yakira Capital Management sold 110,892 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $2.06M.
Yakira Capital Management first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2023 and held it in 1 quarter.
Yakira Capital Management's Intercept Pharmaceuticals, Inc. position peaked at $2.06M in Q3 2023.
0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Yakira Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.